Using Data Analysis For Business And Compliance Monitoring


Tuesday, 28th March, 2017


10:00am – 11:00am CET

For organizations with a multi-market presence, the relationship between Data, Analytics and Transparency can be a complex one. In this webinar, the presenters describe the various ways such organizations can use Transparency Data, and how that subsequently directs evolution in their Business Direction/Model. Presenters will also draw from Roche Italy’s own experiences in showing the advantages of using Transparency Data, the various forms of Compliance and the benefits of Substantial Compliance.


Fautso Massimino

Mr. Fausto Massimino
Director Legal, Governance and Compliance, Roche Group, Italy

Alice Cabrio

Ms. Alice Cabrio
Compliance Specialist, Roche Group, Italy

Co-Speaker & Moderator

Mohammad Ovais

Mohammad Ovais
Founder & CEO at qordata


Takeaway From This Webinar:

  • Improved resource allocation, monitoring and internal restructuring as a positive outgrowth of robust transparency structures
  • How strong structures transcend beyond reporting and why transparency must persist beyond reporting deadlines.
  • The role of Transparency in supporting risk identification and business efficiency


  • The difference between Formal and Substantial Compliance
  • The relationship between Risk and Formal Compliance
  • Benefits of Substantial Compliance
  • Internal and External Transparency; Levels of Disclosure

Who Should Attend?

Senior and mid-level Transparency, Corporate Ethics and Legal Professionals from the Life Sciences Industry. Pharma Sales Professionals interested in improving their reporting practices via technology.

Register Now!